The new kit is based on the detection of antibodies against the bacteria of Anaplasma phagocytophila which causes the Human granulocytic anaplasmosis (HGA) disease. The kits are optimized and validated for detection of IgG and IgM antibodies in human serum and plasma.

Clinical Application:

• Confirmatory method to the screening test
• Method for the proof of acute infection
• Method for detailed determination of the presenceof anti-Anaplasma specific antibodies

Advantages:

• Easy interpretation and reproducibility of results
• High sensitivity and specificity
• Compatibility with all commercial immunoblot processing Systems
• Customer support

Test Characteristics: